Posts by vgn1
Global Expansion of Acute Hepatitis Outbreaks in Healthy Children
Global Expansion of Acute Hepatitis Outbreaks in Healthy Children May 5, 2022 Introduction A recent rise in acute hepatitis among children is expanding globally. The UK first reported an unexpected, significant increase in cases of severe acute hepatitis of unknown origin in previously healthy children. According to the WHO (1), as of 21 April 2022,…
Read MoreGlobal Virus Network (GVN) Announces Seven Distinguished International Appointments to Board of Directors
World Leaders In Academia, Business, Government, Healthcare, Philanthropy & Science Commit Their Expertise To Advancing The Development & Expansion Of The GVN Baltimore, MD, USA (May 3, 2022) – The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, today announced…
Read MoreSpecialized Pro-Resolving Mediators (SPMs) as Potential Covid-19 Therapeutic
April 21, 2022 Introduction Our last Perspective described how the timing of the type 1 interferon (IFN) response is a critical early point in determining whether infection with SARS-CoV2 will lead to severe disease or not. IFN activity later in infection, when disease has already developed, is apparently ineffective, and is instead detrimental. Indeed, an…
Read MoreJapanese Encephalitis Virus: Ongoing Public Health Threat
April 7, 2022 Introduction Japanese encephalitis virus (JEV) is the leading cause of vaccine-preventable encephalitis. JEV is a flavivirus (genus Flavivirus, family Flaviviridae) and shares a close genetic and antigenic relationship with West Nile virus, St. Louis encephalitis virus, and Murray Valley encephalitis virus (1). Most people infected with JE do not have symptoms or…
Read MoreGLOBAL VIRUS NETWORK AND ABBOTT LAUNCH PANDEMIC DEFENSE POSTDOCTORAL FELLOWSHIP PROGRAM
The partnership is training the next generation of virologists to combat future pandemic threats, with a focus on pathogen discovery in developing nations Baltimore, Maryland, USA, April 6, 2022 – The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats, and Abbott, the global healthcare company, announce…
Read More‘LIVE’ POLIO VACCINE FIRES UP IMMUNE SYSTEM PROVIDING PROTECTION FROM SARS-CoV-2 INFECTION
Global Virus Network (GVN) studies suggest that the oral polio vaccine can protect people in developing nations that do not yet have access to COVID vaccines Baltimore, Maryland, USA, March 31, 2022: Two new studies from the Global Virus Network (GVN) in partnership with the Petroleum Industry Health Organization of Iran provide evidence that getting…
Read MoreImpact of Interferon on Disease Severity of Covid-19
Impact of Interferon on Disease Severity of Covid-19 March 28, 2022 Introduction Types 1 and 3 interferon (IFN) expression and activity have been shown to play a significant role in determining the disease severity of SARS-CoV-2 infection. It is becoming clear that the timing of IFN expression is critical in the efficacy of the early…
Read MoreStrategies to Eradicate Transmission of Poliovirus and Paralytic Poliomyelitis
Strategies to Eradicate Transmission of Poliovirus and Paralytic Poliomyelitis March 23, 2022 Introduction Polio (poliomyelitis) is a highly infectious disease that mostly affects children under 5 years of age. The causative agent, poliovirus, replicates in the gut but in some cases can invade the central nervous system and cause permanent paralysis (approximately one in 200…
Read MoreGlobal Virus Network Adds the Aegis Consortium as Newest Center of Excellence
Baltimore, Maryland, USA, March 23, 2022: The Global Virus Network (GVN), representing 69 Centers of Excellence and 11 Affiliates in 37 countries comprising foremost experts in every class of virus causing disease in humans and some animals, and the Aegis Consortium at the University of Arizona Health Sciences announced today the induction of Aegis as…
Read MoreGVN Adds the Centre Scientifique de Monaco as Newest Member to Combat Viral Threats
Baltimore, Maryland, USA, March 22, 2022: The Global Virus Network (GVN), representing 69 Centers of Excellence and 11 Affiliates in 37 countries comprising foremost experts in every class of virus causing disease in humans, and the Centre Scientifique de Monaco (CSM) announced CSM as GVN’s newest Affiliate. “Just last year, we co-hosted a significant international…
Read More